Richard Kim, M.D.
| Appointed: |
2006 |
| Gender: |
Male |
| Languages: |
English
Korean |
Solid Tumor Oncology
Biographical Sketch
Richard D. Kim, MD, is Associate Staff in the Department of Solid Tumor Oncology, Section of Gastrointestinal Malignancies at the Cleveland Clinic Taussig Cancer Center and Clinical Assistant professor at the Cleveland Clinic Foundation Case Western Reserve University Lerner College of Medicine. He is board-certified in internal medicine and medical oncology.
Dr. Kim completed a six-year, Bachelor of Science and medical degree program at the University of Miami School of Medicine and completed his internship in internal medicine at New York University Downtown Hospital, N.Y. He completed a residency in internal medicine at University of Illinois at Chicago and a post-doctoral fellowship in hematology and medical oncology at Yale University Comprehensive Cancer Center, New Haven, Conn.
He is a principal investor in many trials of novel drugs for gastrointestinal tumors and has published in many journals including Lancet Oncology. He is a member of the American Society of Clinical Oncology and reviews articles submitted for publication in Cancer Chemotherapy and Pharmacology, Diseases of the Esophagus, Clinical Colorectal Cancer and Oncology.
Education & Fellowships
| Medical School: | University of Miami Miller School of Medicine, Miami, FL |
|
| Internship: | New York University Downtown Hospital, Internal Medicine, New York, NY |
| Residency: | University of Illinois at Chicago Hospitals, Internal Medicine, Chicago, IL |
| Fellowship: | Yale University Department of Cancer Center, Hematology/Oncology, New Haven, CT |
| Other Education: | (Undergraduate) University of Miami, Coral Gables, FL |
Certifications
Medical Oncology
Internal Medicine
Specializes in Diseases and Conditions
Specializes in Services
Industry Relationships
Cleveland Clinic physicians and scientists report if they have any collaborations with the pharmaceutical or medical device industries as part of the Cleveland Clinic’s procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its doctors’ connections with industry and those of their immediate family members. As of 7/30/2008, Dr. Kim has reported no financial relationship with industry that is applicable to this listing. Patients should feel free to contact their doctor about relationships with industry and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic’s policies on collaborations with industry and innovation management, go to our
Integrity in Innovation page.
( † Disclaimer: This search is powered by PubMed, a service of the U.S.
National Library of Medicine. PubMed is a third-party website with no
affiliation with Cleveland Clinic.)
